Mercurial AI Inc.
Mercurial AI Inc. specializes in generating personalized AI-powered health insights for breast cancer patients, utilizing the latest scientific research and guidelines to provide tailored information that meets individual medical needs. Their product, Care Pilot, offers 24/7 support, enabling patients to track symptoms, medications, and lab results while accessing a virtual assistant trained on oncological guidelines. The company aims to enhance patient outcomes, with research indicating that personalized treatments can significantly increase remission rates. Mercurial AI is positioned to revolutionize cancer care through innovative technology that complements traditional healthcare practices.
Mercurial AI Inc.
Mercurial AI Inc. specializes in generating personalized AI-powered health insights for breast cancer patients, utilizing the latest scientific research and guidelines to provide tailored information that meets individual medical needs. Their product, Care Pilot, offers 24/7 support, enabling patients to track symptoms, medications, and lab results while accessing a virtual assistant trained on oncological guidelines. The company aims to enhance patient outcomes, with research indicating that personalized treatments can significantly increase remission rates. Mercurial AI is positioned to revolutionize cancer care through innovative technology that complements traditional healthcare practices.
TL;DR
Headquarters: Chicago, Illinois, United States
Core product: Care Pilot / Sona Health — AI-powered patient support for cancer care
Focus: Personalized, multilingual AI-driven oncology patient support and clinician tools
Employees: 11
Recent funding: Seed round announced Jan 1, 2025
Company Overview
Problem Domain
Oncology patient support, symptom tracking, personalized treatment guidance, and clinician decision-support.
Industry
Healthtech / Healthcare AI
Funding Track Record
Crunchbase lists four investors for this round: Sushant Kapoor, Haytham Elligham, Hariram Ganesh, Amruta Ravan; pre-money valuation reported on Crunchbase as $8M.
Investor Signal
“Has multiple early-stage investors including individual backers named Sushant Kapoor and Amruta Ravan”